Characteristic | % (n) |
---|---|
Severity of substance use at admissionb | |
 Moderate/Severed | 84% (36 of 43) |
History of polysubstance useb | 57% (26) |
History of injection drug use | 50% (23) |
 Lifetimeb | 50% (23) |
 30 days prior to incarceration | 37% (17) |
Non-OAT substance use services used (30 days prior to incarceration)a | |
 Harm reduction services | 46% (21) |
 Outpatient treatment | 17% (8) |
 Support groups | 15% (7) |
 Inpatient treatment | 9% (4) |
Engagement in OAT (30 days prior to incarceration) | 44% (20) |
Type(s) of OAT (30 days prior to incarceration)ac | |
 Methadone | 95% (19 of 20) |
 Buprenorphine-naloxone | 5% (1 of 20) |
 Both Methadone and buprenorphine-naloxone | 10% (2 of 20) |
 Hydromorphone | 5% (1 of 20) |
Entered CSC on OAT | 39% (18) |
Type(s) of OAT during CSC incarcerationb | |
 Methadone | 67% (31) |
 Buprenorphine-naloxone | 33% (15) |